CoChat

Multimorbidity in Stroke

Open access
Gallacher, Katie I., Jani, Bhautesh D., Hanlon, Peter, Nicholl, Barbara I., Mair, Frances S. · 2019 · Stroke
Cited by 102

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Abstract

The prevalence of long-term conditions is increasing across the world because of improved treatments for acute conditions and an increase in life expectancy. Importantly, people are now commonly living with multiple long-term conditions, and this has important implications for the design and cost of health services. Those with higher numbers of long-term conditions have worse health-related outcomes and use health services more frequently. The presence of multiple conditions adds complexity to disease management; for example, disease-disease and disease-drug interactions are more likely to occur. Co-occurring conditions can be concordant, that is, similar in origin and treatment requirements or discordant, that is, apparently unrelated or requiring different treatments. The terms multimorbidity and comorbidity are used frequently in the medical literature, the first commonly defined as the presence of ≥2 long-term conditions within an individual and the second as the presence of at least 1 long-term condition alongside an index condition. However, it is widely accepted that there is great variation in definitions and this makes comparison of populations difficult. A recent systematic review of systematic reviews examined definitions and methods of measurement of multimorbidity. The authors reported that multimorbidity is most commonly defined as the presence of ≥2 conditions within an individual, but there is variation in whether duration, severity, or clustering of conditions are considered. Various options for the measurement of multimorbidity, including weighted and unweighted options, were also examined, and the authors concluded that the optimum measure depends on the purpose of the study. So, at the present time, there remains no consensus on the optimal approach to measuring multimorbidity. Common measures include the Charlson Comorbidity Index (CCI), Elixhauser Index, and the Cumulative Illness Rating Scale. All are weighted measures, but Elixhauser can also be used in an unweighted form. The CCI was designed to predict mortality and includes 16 conditions (including cerebrovascular disease and hemiplegia). Elixhauser is a more extensive measure, it includes 30 acute and chronic conditions and was developed to predict length of hospital stay, hospital charges, and in-hospital death. The Cumulative Illness Rating Scale was developed to assess the medical burden of chronic illness; it includes 14 body system categories. By contrast, the Liu comorbidity index was specifically constructed from a cohort in Japan to be used in stroke outcomes research. It includes 41 conditions and is a weighted measure. When choosing a measure, a weighted one that has been validated for the outcome being considered may be best, but where evidence is weak or multiple outcomes are being examined, then a simple count of conditions may be appropriate. Importantly, a clear reason for choosing a definition and measure should be provided, and it may even be appropriate to include acute conditions, biopsychosocial factors, and risk factors in the measure if appropriate for the aim of the study. It is currently unclear what data source is best suited to the measurement of multimorbidity; for example, whether routinely collected or self-reported data are more helpful. Traditionally, routinely collected data has been considered to be more valid, but this relies on accurate coding by clinicians and risks missing conditions that are poorly coded such as depression or chronic pain. However, 1 risk with self-reported data is that it may omit conditions less visible to patients, such as chronic kidney disease. This article focuses on multimorbidity in stroke. Stroke survivors commonly have comorbid conditions, and these may arise due to a variety of biopsychosocial reasons. Many concomitant conditions may be concordant, that is, share risk factors and pathological disease processes with stroke, for example heart disease, or may predispose an individual to stroke, for example atrial fibrillation (AF). Other coexisting conditions may occur secondary to stroke, for example vascular dementia, or may be entirely unrelated or discordant, for example breast cancer. When measuring multimorbidity in stroke, how we define comorbidity will affect results; for example inclusion of conditions that are risk factors for stroke will make prevalence of comorbidity high. The recent Academy of Medical Sciences document makes it clear that even if someone only has a cluster of concordant conditions then the person should still be considered multimorbid. There are several reasons why multimorbidity in stroke merits attention. The additive effect of illness burdens from multiple conditions may contribute to poorer health status,

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1161/strokeaha.118.020376

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 6 references

Cited by

See all 102

Metadata

Authors
Gallacher, K. I., Jani, B. D., Hanlon, P., Nicholl, B. I., & Mair, F. S.
Venue
Stroke
Published
2019-07
Volume
50
Issue
7
Pages
1919-1926
ISSN
  • 0039-2499 (ISSN-L)
  • 1524-4628
OpenAlex
W2929437394
Cited by
102
References
6
FWCI
4.31
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Multimorbidity in Stroke. https://app.cochat.ai/papers/10.1161/strokeaha.118.020376
The paper
Gallacher, K. I., Jani, B. D., Hanlon, P., Nicholl, B. I., & Mair, F. S. (2019). Multimorbidity in Stroke. Stroke. https://doi.org/10.1161/strokeaha.118.020376

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.